Job Description
About Us
Do you want to work with a team that is changing science and enabling the next generation of genetic medicines?
The stellar growth in cell and gene therapy has accelerated the need for a better quality, faster and more robust DNA manufacturing technology.
Touchlight has created a new DNA vector for use in advanced genetic medicines that is safer and more efficacious than conventional plasmid DNA. Our unique platform also enables DNA production at unprecedented scale, speed and purity.
We believe that DNA is fundamental to the future of medicine and our CDMO has a focus on the following areas:
* Nucleic acid medicines (mRNA and DNA).
* Ex-vivo and in-vivo cell and genetic medicines.
* Gene therapy using viral vectors and gene editing.
* Autologous and allogenic cell therapy.
Role Overview:
The Group Leader AAV Process Development (Upstream) will be responsible for leading activities in the optimisation of upstream AAV production processes for a range of AAV serotypes, using enzymatically produced dbDNA™ in a transient transfection setting.
The individual will be responsible for a small team and is a...